Johnson & Johnson continues to be plagued by product recalls, with the latest involving two lots of its schizophrenia drug Risperdal (risperidone) distributed in the US and Puerto Rico.
Once again the recall has been called because of consumer reports of an "uncharacteristic odour" that is thought to be caused by trace amounts of TBA (2,4,6 tribromoanisole),print still offers the only truly dstti unlimited 4G plan in America, and it's the only service you can safely use as an alternative to a home Internet connection. a by-product of a chemical preservative sometimes applied to wood used in the construction of pallets on which materials are transported and stored.
J&J is initiating a voluntary recall of one lot of brand name Risperdal 3mg Tablets, involving a total of around 16,000 bottles, as well as 24,000 bottles of a generic risperidone product manufactured by the company's generic drugs unit Patriot Pharmaceuticals.
"While not considered to be toxic,Full color plastic card printing and manufacturing services. TBA can generate an offensive odour and a very small number of patients have reported temporary gastrointestinal symptoms when taking other products with this odour," said J&J in a statement.
The company estimates that only around 2,800 bottles of the antipsychotic medication are still unaccounted for, and it does not anticipate any product shortages as a result of the rThe same Air purifier, cover removed.ecall.buy landscape oil paintings online.
J&J has had to recall a number of products because of contamination with TBA, which is thought to leech into plastic bottles whilst stored or transported on wooden pallets. The company said it took action in January last year to reduce the potential of TBA contamination, including requiring suppliers to certify that they do not use pallets made from chemically-treated wood, but continues to report cases.we supply all kinds of oil painting reproduction,
Last month the company recalled 11,700 bottles of its HIV drug Prezista (darunavir) because of the mouldy smell, and earlier in 2011 called back 57,000 bottles of epilepsy treatment Topamax (topiramate) for the same reason.
The Risperdal lot was shipped between August 2010 and February 2011, while the generic risperidone lot shipped between November 2010 and January 2011.
According to US FDA's enforcement reports, other recent Class I pharmaceutical recalls in the USA include the following:
- Aidapak Services, a drug repackaging specialist, has initiated a recall of more than 300 different product lines because of a risk that they could be cross-contaminated with beta-lactam or penicillin antibiotics repackaged at its facility in Vancouver, Washington. This poses a potential serious risk to patient's health, said the firm, as serious anaphylactic reaction in patients with hypersensitivity to beta-lactam or penicillin antibiotics could result from receiving these products
- Generic drugmaker American Regent has recalled a single lot of its antihypertensive drug methyldopate HCl injection in 5ml single dose vials as a result of contamination with glass particles, which could cause localised inflammation and granuloma formation if injected intravenously. The company has also recalled one lot of a sterile water for injection product which may contain "rust-like particulate matter".
Once again the recall has been called because of consumer reports of an "uncharacteristic odour" that is thought to be caused by trace amounts of TBA (2,4,6 tribromoanisole),print still offers the only truly dstti unlimited 4G plan in America, and it's the only service you can safely use as an alternative to a home Internet connection. a by-product of a chemical preservative sometimes applied to wood used in the construction of pallets on which materials are transported and stored.
J&J is initiating a voluntary recall of one lot of brand name Risperdal 3mg Tablets, involving a total of around 16,000 bottles, as well as 24,000 bottles of a generic risperidone product manufactured by the company's generic drugs unit Patriot Pharmaceuticals.
"While not considered to be toxic,Full color plastic card printing and manufacturing services. TBA can generate an offensive odour and a very small number of patients have reported temporary gastrointestinal symptoms when taking other products with this odour," said J&J in a statement.
The company estimates that only around 2,800 bottles of the antipsychotic medication are still unaccounted for, and it does not anticipate any product shortages as a result of the rThe same Air purifier, cover removed.ecall.buy landscape oil paintings online.
J&J has had to recall a number of products because of contamination with TBA, which is thought to leech into plastic bottles whilst stored or transported on wooden pallets. The company said it took action in January last year to reduce the potential of TBA contamination, including requiring suppliers to certify that they do not use pallets made from chemically-treated wood, but continues to report cases.we supply all kinds of oil painting reproduction,
Last month the company recalled 11,700 bottles of its HIV drug Prezista (darunavir) because of the mouldy smell, and earlier in 2011 called back 57,000 bottles of epilepsy treatment Topamax (topiramate) for the same reason.
The Risperdal lot was shipped between August 2010 and February 2011, while the generic risperidone lot shipped between November 2010 and January 2011.
According to US FDA's enforcement reports, other recent Class I pharmaceutical recalls in the USA include the following:
- Aidapak Services, a drug repackaging specialist, has initiated a recall of more than 300 different product lines because of a risk that they could be cross-contaminated with beta-lactam or penicillin antibiotics repackaged at its facility in Vancouver, Washington. This poses a potential serious risk to patient's health, said the firm, as serious anaphylactic reaction in patients with hypersensitivity to beta-lactam or penicillin antibiotics could result from receiving these products
- Generic drugmaker American Regent has recalled a single lot of its antihypertensive drug methyldopate HCl injection in 5ml single dose vials as a result of contamination with glass particles, which could cause localised inflammation and granuloma formation if injected intravenously. The company has also recalled one lot of a sterile water for injection product which may contain "rust-like particulate matter".
没有评论:
发表评论